About Capecitabine
            
            Class: | Antimetabolite, specifically a pyrimidine analog  
Use: | Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors as part of combination therapy or as a single agent  
Adult dose: | 1250 mg/m² orally twice daily for 14 days, followed by a 7-day rest period in a 21-day cycle; dosage may be adjusted based on tolerance and toxicity  
Pediatric dose: | Safety and efficacy not established; use in pediatric patients is not recommended  
Side effects: | Nausea, vomitin
         
        
            
                
                
                    
                        Drug Class
                    
                    Antimetabolite, specifically a pyrimidine analog
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors as part of combination therapy or as a single agent
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: MYLAN SAS, FRANCE
                    
                    
                    Package Size
                    60s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 133.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1250 mg/m² orally twice daily for 14 days, followed by a 7-day rest period in a 21-day cycle; dosage may be adjusted based on tolerance and toxicity
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established; use in pediatric patients is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, hand-foot syndrome, fatigue, stomatitis, myelosuppression (including neutropenia, anemia, thrombocytopenia)
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to capecitabine or any component of the formulation; severe renal impairment (creatinine clearance < 30 mL/min); concomitant use with sorivudine or its analogs
         
        
        
            
                Important Warnings
            
            Risk of severe diarrhea, dehydration, and electrolyte imbalance; monitor for signs of myelosuppression; caution in patients with hepatic impairment; potential for increased toxicity in elderly patients; avoid use in pregnant or breastfeeding women due to potential harm to the fetus or infant
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.